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Background: Micro-computed tomography (micro-CT) is a novel tool for monitoring acute and chronic disease
states in small laboratory animals. Its value for assessing progressive lung fibrosis in mice has not been reported so
far. Here we examined the importance of in vivo micro-CT as non-invasive tool to assess progression of pulmonary
fibrosis in mice over time.
Methods: Pulmonary fibrosis was induced in mice by intratracheal delivery of an adenoviral gene vector encoding
biologically active TGF-ß1 (AdTGF-ß1). Respiratory gated and ungated micro-CT scans were performed at 1, 2, 3,
and 4 weeks post pulmonary adenoviral gene or control vector delivery, and were then correlated with respective
histopathology-based Ashcroft scoring of pulmonary fibrosis in mice. Visual assessment of image quality and
consolidation was performed by 3 observers and a semi-automated quantification algorithm was applied to
quantify aerated pulmonary volume as an inverse surrogate marker for pulmonary fibrosis.
Results: We found a significant correlation between classical Ashcroft scoring and micro-CT assessment using both
visual assessment and the semi-automated quantification algorithm. Pulmonary fibrosis could be clearly detected in
micro-CT, image quality values were higher for respiratory gated exams, although differences were not significant.
For assessment of fibrosis no significant difference between respiratory gated and ungated exams was observed.
Conclusions: Together, we show that micro-CT is a powerful tool to assess pulmonary fibrosis in mice, using both
visual assessment and semi-automated quantification algorithms. These data may be important in view of pre-
clinical pharmacologic interventions for the treatment of lung fibrosis in small laboratory animals.
Background
Pulmonary fibrosis is a severe, chronic lung disease,
which is associated with high mortality rates, afflicting
more than five million patients worldwide [1]. Its most
severe form, idiopathic pulmonary fibrosis (IPF) is typi-
cally associated with an average survival of 2-5 years
from time of diagnosis [2,3]. Depending on the underly-
ing cause, progression of pulmonary fibrosis is associated
with alveolar epithelial cell injury and hyperplasia,
inflammatory leukocyte accumulations within the
bronchoalveolar space and lung parenchymal tissue, as
well as fibroblast hyperplasia and exuberant deposition of
extracellular matrix (ECM) components such as collagen
and fibronectin in the lungs, eventually leading to forma-
tion of honey comb cysts and scar tissue [2,4]. Specifically
in IPF, immunosuppressive and anti-inflammatory thera-
pies have proved to be ineffective in preventing the fatal
consequences of lung tissue remodelling characterizing
pulmonary fibrosis.
Over the past few years, it has become evident that
animal model systems to study the pathogenesis of lung
fibrosis in rodents need to be more carefully evaluated
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[4]. As an example, application of the anti-neoplastic
drug bleomycin into the lungs of mice or rats is the
most frequently employed model system to study the
pathogenesis of this devastating lung disease in small
laboratory animals. However, in contrast to human lung
fibrosis frequently developing over years and decades,
bleomycin treatment of mice is characterized by early
alveolar epithelial cell injury and acute lung inflamma-
tion followed by a transient lung fibrotic response,
thereby not adequately reflecting human disease pro-
gression [4]. Another previously described model system
to initiate fibrosis in small laboratory animals makes use
of somatic cell gene transfer of biologically active trans-
forming growth factor-b1, which, due to its unique
fibrogenic characteristics, has been shown to trigger
slowly progressing lung fibrosis in rats, which is irrever-
sible and lacks acute inflammatory episodes [5].
Diagnostic tools to assess the degree of lung fibrosis in
humans currently include lung CT scans, lung function
tests and histological examinations of lung tissue biop-
sies. In mice, where complete lungs can be removed,
particularly histological and biochemical approaches are
employed to assess the degree of fibrosis [6,7]. In recent
years, small animal imaging has emerged as an innova-
tive and powerful, non-invasive tool to perform follow
up of both acute and chronic disease processes in
laboratory animals over time [8-11]. Various non-inva-
sive techniques such as micro-CT, micro-positron emis-
sion tomography (micro-PET), and magnetic resonance
imaging (MRI) are innovative tools that may be useful
for evaluation of novel anti-fibrogenic therapeutic strate-
gies in mouse models in vivo. However, systematic
micro-computed tomography-based analysis of develop-
ing lung fibrosis induced by gene transfer of biologically
active transforming growth factor-b1a sc o m p a r e dt o
classical histopathological approaches to monitor fibrotic
disease progression in mice using both visual assessment
and semi-automated quantification algorithms has not
been reported so far.
Therefore, in the current study, pulmonary fibrosis
was induced in mice by gene transfer of biologically
active transforming growth factor-b1, and fibrotic dis-
ease progression was evaluated by micro-computed
tomography and then correlated to histological scoring
of lung fibrosis as pioneered by Ashcroft [12].
Methods
Adenoviral vectors
Two adenoviral vectors were employed, which were
constructed as outlined in detail previously [5]. AdTGF-
b1
223-225 contains the cDNA of the coding region of
full-length porcine TGF-b1, while containing a mutation
of cysteine to serine at positions 223 and 225, rendering
expressed TGF-b1 biologically active [5]. Empty viral
vector AdDL70-3 constructed as previously described
was used as control [13].
Induction of pulmonary fibrosis
Groups of female C57BL/6 mice (30 mice, age 8-12
weeks, weight 18-20 g) were either infected with AdTGF-
b1
223-225 (herewith referred to as AdTGF-b1, 18 mice) or
control vector AdDL70-3 (12 mice) via intratracheal
instillation, as described recently in detail [6,14,15].
Briefly, anaesthetized mice were orotracheally intubated
with an Abbocath (Abbott, Wiesbaden, Germany), fol-
lowed by careful intratracheal instillation of adenoviral
vectors (~1 × 10
8 plaque-forming units [PFU] per
mouse) suspended in a total volume of 50 μlo fp h o s -
phate-buffered saline (PBS). At 1, 2, 3, and 4 weeks after
adenoviral transfer, mice (AdTGF-b1 for week 1-4: n = 3,
n = 6, n = 6, n = 3; AdDL70-3 for week 1-4: n = 3 for
each time point) were subjected to micro-computed
tomography (Figure 1), followed by immediate sacrifice
and isolation of lungs for histopathological evaluation of
the degree of pulmonary fibrosis, using the scoring sys-
tem described by Ashcroft et al. [12].
Lung histology and assessment of pulmonary fibrosis
Complete lungs were inflated in situ with PBS-buffered
(4.5%, pH 7.0) formalin (Roth, Darmstadt, Germany), and
were then carefully removed and immersed in PBS-buf-
fered formalin. Lung tissue samples were paraffin-
embedded, and sections of 5 μm were prepared and
stained with haematoxylin/eosin (H/E) and Masson’so r
Elastica-van-Gieson staining. The degree of lung fibrosis
was determined according to the method described by
Ashcroft and colleagues [12], employing a numerical scal-
ing system in lung samples ranging from 0 (normal lung)
to 8 (total fibrous obliteration of the field). The mean
degree of lung fibrosis according to the definitions by Ash-
c r o f te ta l .[ 1 2 ]w a sc a l c u l a t e df r o mi n d i v i d u a ls c o r e so f
~15 microscopic fields analyzed per mouse lung.
Micro-CT scans of mice
A GE Explore Locus cone-beam micro-CT (GE Health-
care, Chalfont St Giles, GB) was used for data-acquisi-
tion in prone position under isoflurane inhalation
anaesthesia (tube voltage 80 kV, tube current 450 μA,
0.094 mm effective pixel size) with and without respira-
tory gating (i.e. synchronization of acquisition of micro-
CT projections with a timepoint in the respiratory cycle
of the individual mouse). Scanning took approximately
10 and 20 min without and with respiratory gating,
respectively. Respiratory monitoring was performed
using a pressure transducer pad under the animal’s
chest. Images were reconstructed and assessed at a con-
stant window width/window level (5000/2000).
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Three radiologists blinded to the experimental groups
and respiratory gating strategies, independently assessed
image qualities of all individual entire micro CT scans,
using a rating scale ranging from 1 (very good) to 5
(insufficient) and the amount of lung consolidations
using a rating scale ranging from 1 (no consolidation) to
5 (very pronounced consolidation).
Post-processing
D u et ot h ed i f f u s en a t u r eo ff i b r o t i cc o n s o l i d a t i o n s ,
direct quantification of the pathology of lung fibrosis by
measurement of focal fibrotic lesions was not feasible.
Therefore, quantification of aerated lung areas known to
be compromized by developing lung fibrosis was used as
a surrogate marker for progressive lung fibrosis. A
region-growing segmentation algorithm was applied on
each individual entire micro CT scan using the Mevi-
sLab software package (Mevis Research, Bremen, Ger-
many) [16]. The algorithm uses the seed points as
starting points. From these points the segmentation
volume “grows”, with the structures included in the
volume depending on the mathematical parameters. The
segmentation algorithm was originally developed for
quantification of diffuse lung tumors in transgenic mice,
and was slightly modified for its use in the current
study. Segmentation was carried out using 20-40 seed
points, the segmentation threshold tolerance of the
region growing algorithm was set to 2%.
Statistical analysis
All statistical computations have been performed using the
statistical program SPSS 17 (SPSS Inc., Chicago, Ill., USA)
The significance level of all tests has been set to 0.05 (5%).
Because most of the observed variables were ordinal scaled
we used non-parametric tests for statistical analysis. Signif-
icance of differences in image quality values were tested
for all three observers in respiratory gated and respiratory
ungated exams using a Wilcoxon signed ranks test.
Furthermore, significance of differences in consolidation
assessment values for respiratory gated and respiratory
ungated exams was tested using a Wilcoxon signed ranks
test for all three observers. Differences between the assess-
ment of the 3 observers were evaluated comparing the
95% confidence interval for the mean for assessment
values of the image quality for respiratory gated/ungated
exams and the assessment values of the consolidation
assessment for respiratory gated/ungated exams.
Correlation of the Ashcroft histology scores (assessing
the degree of fibrosis) and the lung consolidation values
(obtained by assessment of the images by three obser-
vers) was calculated for respiratory ungated/respiratory
Figure 1 Respiratory ungated in vivo micro-CT at 1, 2, 3 and 4 weeks after intratracheal instillation of control vector or AdTGFb1.( A )
Lung micro-CT of mice treated with the control vector AdDL70-3. (B) Lung micro-CT of mice treated with AdTGF-b1. Only minor changes are
seen in the control group, the consolidation in the fibrosis group is illustrated with pronounced micro-CT consolidation at 2 and 3 weeks.
Representative images are shown.
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rank correlation coefficient for ordinary scaled variables.
Correlation of the Ashcroft histology scores and the
lung segmentation values (obtained by the semiauto-
mated segmentation routine described above) was calcu-
lated for respiratory ungated and respiratory gated
exams using a Pearson correlation for continuous vari-
ables. To assess differences between the 4 time points
for histology scores, visual consolidation assessment and
segmentation of aerated lung areas 95% confidence
intervals were plotted against the 4 time points and dif-
ferences were tested for significance.
Results
In vivo micro-CT imaging of mouse lungs after
intrapulmonary delivery of control vector or AdTGFb1
As shown in Figure 1 micro-CT imaging of mouse lungs
subjected to treatment with control vector or application
of AdTGFb1 for up to 4 weeks revealed that no major
consolidations were detectable in control vector treated
mice, whereas AdTGFb1 treatment of mice provoked
strong consolidations easily detectable particularly on
weeks 2 and 3 post-treatment (Figure 1).
Assessment of image quality and consolidations in
respiratory gated as compared to ungated exams of
fibrosing lungs
We next questioned whether detection of consolidations
in fibrosing mouse lungs would differ between obser-
vers. However, initial comparative image quality assess-
ment between three different observers revealed only
slightly increased mean image quality values in respira-
tory gated (MVSD 2.70, MVCVF 2.33, MVTR 2.27) as
compared to ungated exams of fibrosing lungs (MVSD
2.33, MVCVF 2.10, MVTR 1.97). Moreover, all three
observers determined similar consolidation assessment
values for respiratory gated (MVSD 2.13, MVCVF 2.40,
MVTR 2.30) as compared to ungated exams (MVSD 2.13,
MVCVF 2.43, MVTR 2.40).
Regarding the assessment variability between the 3
observers, we found that the lower and upper bound
of the 95% confidence interval for the mean for the 3
observers showed no relevant differences except for
the image quality assessment in gated exams. Here,
lower and upper bound of the 95% confidence interval
f o rt h em e a nw e r ed i s t i n c t l yh i g h e rf o ro b s e r v e rS D .
The Cohen’s kappa statistic also showed significant
agreement between nearly all observer scores, but no
significant agreement was found for the image quality
evaluation scores by observers SD and TR for gated
(p = 0.051) and ungated exams (p = 0.699).Overall,
these data illustrate that visual assessment of micro-
CT based lung fibrosis in mice was independent of the
observer.
Correlation of histological grading of lung fibrosis with
micro-CT based fibrosis grading
We next compared classical Ashcroft scoring with
micro-CT based evaluation of TGFb-1 induced lung
fibrosis in mice. Ashcroft histology scores and lung con-
solidation values showed significant correlations for all
observers and respiratory gated as well as respiratory
ungated exams using Spearman’s rank correlation coeffi-
cient (p < 0.001, Figure 2). Moreover, we also assessed
progression of pulmonary fibrosis in mice by making
use of a semi-automated region growing segmentation
algorithm, where aerated lung volume was used as a
surrogate marker for pulmonary fibrosis, which is illu-
strated in Figure 3. Ashcroft histology scores and lung
segmentation values showed significant negative correla-
tion using a Pearson correlation test for respiratory
gated (p = 0.004) and respiratory ungated exams (p =
0.006) (Figure 4).
Due to the limited number of study objects within
each group (AdTGF-b1 for weeks 1-4: n = 3, n = 6, n =
6, n = 3), we were not able to detect significant differ-
ences between different time points for visual consolida-
tion assessment and segmentation of aerated lung areas.
However, to better exemplify the time course of fibrosis
in mice on days 7, 14, 21, and 28 post treatment, mean
values and standard deviations for Ashcroft histology
scores and visual assessment of all three observers for
ungated exams are given (histology for control group:
0,15 ± 0,03; 0,14 ± 0,01; 0,17 ± 0,07; 0,15 ± 0,05/histol-
ogy for fibrosis group: 1,79 ± 0,58; 2,13 ± 0,5; 1,67 ±
0,84; 1,64 ± 0,45/visual consolidation assessment scores
for control group: 1,11 ± 0,19; 1,11 ± 0,19; 1,22 ± 0,38;
1,11 ± 0,19/visual consolidation assessment scores for
fibrosis group: 3,56 ± 0,58; 4,06 ± 1,11; 2,50 ± 0,89; 2,00
± 0,72).
Discussion
I nt h i ss t u d yw ee v a l u a t e dt h eu s eo fm i c r o - C Tf o r
assessment of pulmonary fibrosis induced by adenoviral
gene transfer of biologically active TGF-b1i nm i c e .W e
found micro-CT imaging to be a highly valuable tool to
study pulmonary fibrosis progression in mice using both
visual inspection of lung images and a semi-automated
segementation algorithm that estimates aerated lung
areas as a surrogate marker inversely correlating with
developing lung fibrosis in mice.
Micro-CT allows a detailed assessment of lung mor-
phology due to high density differences and well defined
borders between air and lung tissue. However, one lim-
itation of this method is that the activity of inflamma-
tory processes can only be assessed by secondary
characteristics by micro-CT, such as affection of
adjacent strucutre or pleural effusion. Other imaging
techniques such as magnetic resonance imaging (MRI),
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imaging could provide functional data, with micro-PET
beeing an especially promising candidate to robustly
assess inflammatory activity by increase of glucose meta-
bolism as detected by
18F-fluoro-deoxyglucose micro-
PET [17-19], which might be particularly relevant in
terms of monitoring acute exacerbations of pulmonary
fibrosis in small laboratory animals.
Image quality is of equal importance in small animal
imaging as in human imaging. However, data on imaging
protocols are still not extensive. One major issue
addressed in previous studies relates to respiratory gat-
ing. Various gating techniques, including prospective and
retrospective as well as intrinsic and extrinsic techniques
have revealed that mostly, gated imaging resulted in
increased image quality [20,21]. In the current study, we
found that mean values for image quality were better in
gated exams for all observers, however differences were
minor and not significant. Both gated and ungated exams
resulted in a highly significant correlation with histology-
based Ashcroft scores. Therefore, we conclude that gat-
ing should be applied whenever possible, but is not an
absolutely critical issue when this setup is not available.
A further important aspect of micro CT imaging of
normal or fibrosing mouse lungs is the time-point in
the respiratory cycle when images are acquired. Due to
the typical respiratory pattern in anesthesia, with a short
breath followed by a long expiratory plateau, imaging is
mostly performed in expiration. Under those experimen-
tal conditions, where intratracheal intubation and venti-
lation is performed, micro-CT imaging can also be
performed in inspiration, as a different and consistent
respiratory pattern can be created [22]. Without gating,
imaging is effectively performed during expiration, due
to the longer period of time as compared to inspiration
that only represents a small fraction contributing to the
average imaging time-point.
The semi-automated segmentation routine described
in this study was found to assess consolidations in a
quantitative way, as proven by the significant correlation
of segmentation values with Ashcroft-based histological
grading. To a minor degree, observer interaction is pos-
sible, as the observer has to place its own seed points
for the region growing algorithm. As seed points have
to be placed carefully within aerated lung areas, inadver-
tent positioning of seed points within non-aerated lung
areas may increase the likelihood that consolidated aer-
eas will be included in the segmentation volume and
thus may cause assessment bias, which however, accord-
ing to the presented data, appears to be very low.
In the current study, segmentation volumes were not
correlated with total lung volume or body weight of
Figure 2 Correlation of visual consolidation assessment and histological assessment by Ashcroft scoring in animals after treatment
with control vector AdDL70-3 (A, showing very low Ashcroft histology scores (i.e. no fibrosis), and low visual consolidation
assessment scores) or AdTGF-b1 (B). Mean consolidation assessment values of the 3 observers are plotted against Ashcroft scores of each
animal in respiratory gated and respiratory ungated exams, as indicated. Linear interpolation is given for respiratory gated and ungated exams,
respectively. Note the different scaling.
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Page 5 of 8Figure 4 Correlation of aerated lung volume determined by region growing segmentation with histological assessment of lung
fibrosis by Ashcroft scoring in mice treated with control vector (A, showing very low Ashcroft histology scores (i.e. no fibrosis) and
normal aerated lung volume) or AdTGF-b1 (B). Aerated lung volumes are plotted against Ashcroft scores for each animal in respiratory gated
and respiratory ungated exams, as indicated. Linear interpolation is given for respiratory gated and ungated exams, respectively. Note the
different scaling.
Figure 3 Semiautomated region growing segmentation for assessment of pulmonary consolidation 3 weeks after instillation of
control vector AdDL70-3 (A-C) or AdTGF-b1 (D-E). Aerated lung volume is used as an inverse surrogate marker for pulmonary fibrosis. (A, D)
Axial micro-CT. (B, E) Placement of seed points for the region growing segmentation in the aerated lung. Seed points are enlarged for better
detection. (C, F) Segmentation result shows aerated lung volume in white.
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ences in expiratory total lung volumes between indivi-
dual mice of the same age and strain are neglectable, it
may be largely excluded that this aspect may have con-
founded the reported correlations. Future algorithms
might take segmentation assessments of the entire lung
into account, thereby allowing the correlation of mea-
sured consolidations with total lung volumes, or simply
by employing a quotient taking the body weight into
account.
Additionally, different techniques of fibrosis assess-
ment could be applied. A promising approach is the
measurement of CT densities expressed by Hounsfield
Units and assessing fibrosis not only by consolidation
but also by evaluation of density distribution [23]. Mor-
phological pattern assessment as applied in human
fibrosis assessment has also been described for imaging
of lung fibrosis in small laboratory animals [24,25].
However, such approaches would be dependent on an
image quality that is consistently comparable to human
imaging, which is technically still difficult to achieve in
in vivo imaging of small laboratory animals.
In another study we evaluated the applied radiation
dose for the protocols used in this study applying phan-
tom and cadaver thermoluminescence dosimetric mea-
surements (own unpublished observations). The
expected mean doses in an average C57BL/6 mouse for
the respiratory gated and ungated protocols used in this
s t u d yw e r e2 0 1m G ya n d1 9 4m G yr e s p e c t i v e l y .T h e
expected mean value for an estimated time of 1 minute
fluoroscopy to determine the scan field of view was
22 mGy. Day et al. reported that high radiation doses of
7 - 9 Gy did not result in significant lung fibrosis in
mice after 90 days, just few microscopically small col-
lagen-rich foci were detected subpleurally [26]. There-
fore, it appears that radiation-induced fibrosis can be
largely excluded even whens e r i a le x a m i n a t i o n sa r e
performed.
Human lung fibrosis differs from the animal model
reported here, as it is irreversible and shows typical
morphological patterns in computed tomography repre-
senting definite fibrotic changes of the lung. The appli-
cation of the methods reported for imaging in human
lung fibrosis therefore is not intended. We believe that
the currently applied technique will primarily be helpful
to better assess e.g. novel therapeutic strategies for the
treatment of pulmonary fibrosis in rodent model
systems.
Conclusion
In conclusion, the current study shows that respiratory
gated/ungated micro-CT allows valid in vivo evaluation
of the degree of pulmonary fibrosis in mice using both
visual assessment and semi-automated quantification
algorithms. Micro-CT thus offers a non-invasive imaging
tool for evaluation of novel therapeutic strategies for the
treatment of pulmonary fibrosis in mice.
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